Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Raw Materials (2019 - 2025)

Historic Raw Materials for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $27.2 million.

  • Outset Medical's Raw Materials rose 575.81% to $27.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $27.2 million, marking a year-over-year increase of 575.81%. This contributed to the annual value of $27.2 million for FY2025, which is 575.81% up from last year.
  • Latest data reveals that Outset Medical reported Raw Materials of $27.2 million as of Q4 2025, which was up 575.81% from $26.0 million recorded in Q3 2025.
  • Outset Medical's Raw Materials' 5-year high stood at $27.2 million during Q4 2025, with a 5-year trough of $10.9 million in Q1 2021.
  • Its 5-year average for Raw Materials is $20.9 million, with a median of $20.8 million in 2022.
  • Its Raw Materials has fluctuated over the past 5 years, first skyrocketed by 15093.3% in 2021, then crashed by 929.54% in 2023.
  • Quarter analysis of 5 years shows Outset Medical's Raw Materials stood at $18.1 million in 2021, then increased by 13.85% to $20.6 million in 2022, then dropped by 9.3% to $18.7 million in 2023, then skyrocketed by 37.41% to $25.7 million in 2024, then rose by 5.76% to $27.2 million in 2025.
  • Its Raw Materials was $27.2 million in Q4 2025, compared to $26.0 million in Q3 2025 and $26.8 million in Q2 2025.